{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:33:30Z","timestamp":1769171610650,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13075-015-0756-5","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T10:24:29Z","timestamp":1440671069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study"],"prefix":"10.1186","volume":"17","author":[{"given":"Silje","family":"Reiseter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnar","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May Brit","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond Mogens","family":"Aalokken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torhild","family":"Garen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathrine","family":"Brunborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelija","family":"Abraityte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"756_CR1","first-page":"911","volume":"13","author":"M Giordano","year":"1986","unstructured":"Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol. 1986;13:911\u20136.","journal-title":"J Rheumatol"},{"key":"756_CR2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","volume":"31","author":"VD Steen","year":"1988","unstructured":"Steen VD, Powell DL, Medsger Jr TA. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988;31:196\u2013203.","journal-title":"Arthritis Rheum"},{"key":"756_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.113930","volume":"58","author":"V Viswanath","year":"2013","unstructured":"Viswanath V, Phiske MM, Gopalani VV. Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations. Indian J Dermatol. 2013;58:255\u201368.","journal-title":"Indian J Dermatol"},{"key":"756_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","volume":"364","author":"M Kuwana","year":"2004","unstructured":"Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet. 2004;364:603\u201310.","journal-title":"Lancet"},{"key":"756_CR5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis. 2007;66:940\u20134.","journal-title":"Ann Rheum Dis"},{"key":"756_CR6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/BOR.0b013e3283588de4","volume":"24","author":"LA Murray","year":"2012","unstructured":"Murray LA, Rubinowitz A, Herzog EL. Interstitial lung disease: is interstitial lung disease the same as scleroderma lung disease? Curr Opin Rheumatol. 2012;24:656\u201362.","journal-title":"Curr Opin Rheumatol"},{"key":"756_CR7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/rheumatology\/keu310","volume":"54","author":"ST Flam","year":"2015","unstructured":"Flam ST, Gunnarsson R, Garen T, Norwegian MSG, Lie BA, Molberg O. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatol. 2015;54:528\u201335.","journal-title":"Rheumatol"},{"key":"756_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rdc.2005.04.009","volume":"31","author":"J Swanton","year":"2005","unstructured":"Swanton J, Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin N Am. 2005;31:421\u201336.","journal-title":"Rheum Dis Clin N Am"},{"key":"756_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.berh.2012.01.009","volume":"26","author":"OD Ortega-Hernandez","year":"2012","unstructured":"Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol. 2012;26:61\u201372.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"756_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.rdc.2005.04.006","volume":"31","author":"T Grader-Beck","year":"2005","unstructured":"Grader-Beck T, Wigley FM. Raynaud's phenomenon in mixed connective tissue disease. Rheum Dis Clin N Am. 2005;31:465\u201381.","journal-title":"Rheum Dis Clin N Am"},{"key":"756_CR11","first-page":"S-115","volume":"32","author":"J Huang","year":"2014","unstructured":"Huang J, Li M, Tian Z, Hsieh E, Wang Q, Liu Y, et al. Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. Clin Experimen Rheumatol. 2014;32:S-115\u201321.","journal-title":"Clin Experimen Rheumatol"},{"key":"756_CR12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.130984","volume":"41","author":"B Artim-Esen","year":"2014","unstructured":"Artim-Esen B, Cene E, Sahinkaya Y, Ertan S, Pehlivan O, Kamali S, et al. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center. J Rheumatol. 2014;41:1304\u201310.","journal-title":"J Rheumatol"},{"key":"756_CR13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"MO Becker","year":"2014","unstructured":"Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, et al. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med. 2014;190:808\u201317.","journal-title":"Am J Respir Crit Care Med"},{"key":"756_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2010.11.001","volume":"30","author":"L Seppinen","year":"2011","unstructured":"Seppinen L, Pihlajaniemi T. The multiple functions of collagen XVIII in development and disease. Matrix Biol. 2011;30:83\u201392.","journal-title":"Matrix Biol"},{"key":"756_CR15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev. 2011;10:590\u20134.","journal-title":"Autoimmun Rev"},{"key":"756_CR16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/ard.2010.140657","volume":"70","author":"JH Distler","year":"2011","unstructured":"Distler JH, Strapatsas T, Huscher D, Dees C, Akhmetshina A, Kiener HP, et al. Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Ann Rheum Dis. 2011;70:1197\u2013202.","journal-title":"Ann Rheum Dis"},{"key":"756_CR17","first-page":"1529","volume":"30","author":"JJ Choi","year":"2003","unstructured":"Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS, et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol. 2003;30:1529\u201333.","journal-title":"J Rheumatol"},{"key":"756_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1756-185X.12130","volume":"16","author":"HM Farouk","year":"2013","unstructured":"Farouk HM, Hamza SH, El Bakry SA, Youssef SS, Aly IM, Moustafa AA, et al. Dysregulation of angiogenic homeostasis in systemic sclerosis. Int J Rheum Dis. 2013;16:448\u201354.","journal-title":"Int J Rheum Dis"},{"key":"756_CR19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","volume":"43","author":"M Hebbar","year":"2000","unstructured":"Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum. 2000;43:889\u201393.","journal-title":"Arthritis Rheum"},{"key":"756_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1155\/MI.2005.144","volume":"2005","author":"B Dziankowska-Bartkowiak","year":"2005","unstructured":"Dziankowska-Bartkowiak B, Waszczykowska E, Zalewska A, Sysa-Jedrzejowska A. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Mediat Inflamm. 2005;2005:144\u20139.","journal-title":"Mediat Inflamm"},{"key":"756_CR21","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/annrheumdis-2011-200657","volume":"71","author":"M Santis De","year":"2012","unstructured":"De Santis M, Bosello SL, Capoluongo E, Inzitari R, Peluso G, Lulli P, et al. A vascular endothelial growth factor deficiency characterises scleroderma lung disease. Ann Rheum Dis. 2012;71:1461\u20135.","journal-title":"Ann Rheum Dis"},{"key":"756_CR22","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4:R11.","journal-title":"Arthritis Res"},{"key":"756_CR23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.080516","volume":"36","author":"LK Hummers","year":"2009","unstructured":"Hummers LK, Hall A, Wigley FM, Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol. 2009;36:576\u201382.","journal-title":"J Rheumatol"},{"key":"756_CR24","first-page":"508","volume":"24","author":"B Dziankowska-Bartkowiak","year":"2006","unstructured":"Dziankowska-Bartkowiak B, Waszczykowska E, Dziankowska-Zaboroszczyk E, de Graft-Johnson JE, Zalewska A, Luczynska M, et al. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement. Clin Exp Rheumatol. 2006;24:508\u201313.","journal-title":"Clin Exp Rheumatol"},{"key":"756_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.140047","volume":"42","author":"AM Hoffmann-Vold","year":"2015","unstructured":"Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O. Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism classification criteria for systemic sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol. 2015;42:60\u20133.","journal-title":"J Rheumatol"},{"key":"756_CR26","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","volume":"67","author":"AM Hoffmann-Vold","year":"2015","unstructured":"Hoffmann-Vold AM, Aal\u00f8kken TM, Lund MB, Garen T, Midtvedt O, Brunborg C, et al. Predictive value of serial HRCT analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol. 2015;67:2205\u201312.","journal-title":"Arthritis Rheumatol"},{"key":"756_CR27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2010.143792","volume":"70","author":"R Gunnarsson","year":"2011","unstructured":"Gunnarsson R, Molberg O, Gilboe IM, Gran JT, Group PS. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70:1047\u201351.","journal-title":"Ann Rheum Dis"},{"key":"756_CR28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/kes430","volume":"52","author":"R Gunnarsson","year":"2013","unstructured":"Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut AS, et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatol. 2013;52:1208\u201313.","journal-title":"Rheumatol"},{"key":"756_CR29","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","volume":"71","author":"R Gunnarsson","year":"2012","unstructured":"Gunnarsson R, Aalokken TM, Molberg O, Lund MB, Mynarek GK, Lexberg AS, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71:1966\u201372.","journal-title":"Ann Rheum Dis"},{"key":"756_CR30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.121390","volume":"40","author":"AM Hoffmann-Vold","year":"2013","unstructured":"Hoffmann-Vold AM, Molberg O, Midtvedt O, Garen T, Gran JT. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol. 2013;40:1127\u201333.","journal-title":"J Rheumatol"},{"key":"756_CR31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/rheumatology\/kes076","volume":"51","author":"AM Hoffmann-Vold","year":"2012","unstructured":"Hoffmann-Vold AM, Midtvedt O, Molberg O, Garen T, Gran JT. Prevalence of systemic sclerosis in south-east Norway. Rheumatol. 2012;51:1600\u20135.","journal-title":"Rheumatol"},{"key":"756_CR32","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"756_CR33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148\u201359.","journal-title":"Am J Med"},{"key":"756_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","volume":"40","author":"E Hachulla","year":"2011","unstructured":"Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78\u201383.","journal-title":"Clin Rev Allergy Immunol"},{"key":"756_CR35","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Galie","year":"2009","unstructured":"Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493\u2013537.","journal-title":"Eur Heart J"},{"key":"756_CR36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697\u2013722.","journal-title":"Radiology"},{"key":"756_CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"756_CR38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720\u201335.","journal-title":"Eur Respir J"},{"key":"756_CR39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11926-012-0302-2","volume":"15","author":"A Yaqub","year":"2013","unstructured":"Yaqub A, Chung L. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2013;15:302.","journal-title":"Curr Rheumatol Rep"},{"key":"756_CR40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","volume":"44","author":"N Bose","year":"2015","unstructured":"Bose N, Chiesa-Vottero A, Chatterjee S. Scleroderma renal crisis. Semin Arthritis Rheum. 2015;44:687\u201394.","journal-title":"Semin Arthritis Rheum"},{"key":"756_CR41","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809\u201315.","journal-title":"Ann Rheum Dis"},{"key":"756_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95:109\u201316.","journal-title":"Circ Res"},{"key":"756_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semarthrit.2010.08.004","volume":"41","author":"S Chatterjee","year":"2011","unstructured":"Chatterjee S. Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum. 2011;41:19\u201337.","journal-title":"Semin Arthritis Rheum"},{"key":"756_CR44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11926-012-0296-9","volume":"14","author":"LA Saketkoo","year":"2012","unstructured":"Saketkoo LA, Distler O. Is there evidence for vasculitis in systemic sclerosis? Curr Rheumatol Rep. 2012;14:516\u201325.","journal-title":"Curr Rheumatol Rep"},{"key":"756_CR45","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/ATVBAHA.113.301533","volume":"33","author":"T Dodd","year":"2013","unstructured":"Dodd T, Wiggins L, Hutcheson R, Smith E, Musiyenko A, Hysell B, et al. Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin. Arterioscler Thromb Vasc Biol. 2013;33:1339\u201349.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"756_CR46","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10875-012-9735-7","volume":"32","author":"WJ Peng","year":"2012","unstructured":"Peng WJ, Yan JW, Wan YN, Wang BX, Tao JH, Yang GJ, et al. Matrix metalloproteinases: a review of their structure and role in systemic sclerosis. J Clin Immunol. 2012;32:1409\u201314.","journal-title":"J Clin Immunol"},{"key":"756_CR47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.121272","volume":"40","author":"A Hajas","year":"2013","unstructured":"Hajas A, Szodoray P, Nakken B, Gaal J, Zold E, Laczik R, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40:1134\u201342.","journal-title":"J Rheumatol"},{"key":"756_CR48","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","volume":"21","author":"P Szodoray","year":"2012","unstructured":"Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21:1412\u201322.","journal-title":"Lupus"},{"key":"756_CR49","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/ATVBAHA.113.301704","volume":"33","author":"J Arnlov","year":"2013","unstructured":"Arnlov J, Ruge T, Ingelsson E, Larsson A, Sundstrom J, Lind L. Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts. Arterioscler Thromb Vasc Biol. 2013;33:2689\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"756_CR50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000368220","volume":"130","author":"T Ueland","year":"2014","unstructured":"Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, et al. Predictive value of endostatin in chronic heart failure patients with poor kidney function. Cardiology. 2014;130:17\u201322.","journal-title":"Cardiology"},{"key":"756_CR51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","volume":"21","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant. Trends Cardiovasc Med. 2011;21:204\u201310.","journal-title":"Trends Cardiovasc Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0756-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:24:32Z","timestamp":1498242272000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/17\/1\/231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0756-5","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]},"article-number":"231"}}